IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus

Objective: To define the role of IgA antibodies to cardiolipin (aCL) and IgA antibodies to beta-2 glycoprotein 1 (anti-β(2)-GP1) in the development of vascular complications in patients with antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). Material and methods: A total of 187...

Descripción completa

Detalles Bibliográficos
Autores principales: Reshetnyak, Tatiana, Cheldieva, Fariza, Cherkasova, Maria, Lila, Alexander, Nasonov, Evgeny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409442/
https://www.ncbi.nlm.nih.gov/pubmed/36012697
http://dx.doi.org/10.3390/ijms23169432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409442/
https://www.ncbi.nlm.nih.gov/pubmed/36012697
http://dx.doi.org/10.3390/ijms23169432

Ejemplares similares